BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Takaoka S, Hirotsu Y, Ohyama H, Mochizuki H, Amemiya K, Oyama T, Ashizawa H, Yoshimura D, Nakagomi K, Hosoda K, Suzuki Y, Kojima Y, Omata M. Molecular subtype switching in early-stage gastric cancers with multiple occurrences. J Gastroenterol 2019;54:674-86. [DOI: 10.1007/s00535-019-01547-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Hirotsu Y, Nagakubo Y, Amemiya K, Oyama T, Mochizuki H, Omata M. Microsatellite instability status is determined by targeted sequencing with MSIcall in 25 cancer types. Clinica Chimica Acta 2020;502:207-13. [DOI: 10.1016/j.cca.2019.11.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Nagakubo Y, Hirotsu Y, Amemiya K, Oyama T, Mochizuki H, Omata M. Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR. BMC Med Genomics 2019;12:162. [PMID: 31711486 DOI: 10.1186/s12920-019-0610-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
3 Hirotsu Y, Yokoyama H, Amemiya K, Hagimoto T, Hosaka K, Oyama T, Mochizuki H, Omata M. Genomic Profiling Identified ERCC2 E606Q Mutation in Helicase Domain Respond to Platinum-Based Neoadjuvant Therapy in Urothelial Bladder Cancer. Front Oncol 2020;10:1643. [PMID: 32984035 DOI: 10.3389/fonc.2020.01643] [Reference Citation Analysis]
4 Nakamura K, Urabe Y, Kagemoto K, Yuge R, Hayashi R, Ono A, Hayes CN, Oka S, Ito M, Nishisaka T, Tanabe K, Arihiro K, Ohdan H, Tanaka S, Chayama K. Genomic Characterization of Non-Invasive Differentiated-Type Gastric Cancer in the Japanese Population. Cancers (Basel) 2020;12:E510. [PMID: 32098350 DOI: 10.3390/cancers12020510] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Sakuta K, Sasaki Y, Abe Y, Sato H, Shoji M, Yaoita T, Yagi M, Mizumoto N, Onozato Y, Kon T, Koseki A, Sato S, Murakami R, Miyano Y, Ueno Y. Somatic alterations and mutational burden are potential predictive factors for metachronous development of early gastric cancer. Sci Rep 2020;10:22071. [PMID: 33328548 DOI: 10.1038/s41598-020-79195-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen O, Shao ZY, Qiu X, Zhang GP. Multiple gastric adenocarcinoma of fundic gland type: A case report. World J Clin Cases 2019; 7(18): 2871-2878 [PMID: 31616705 DOI: 10.12998/wjcc.v7.i18.2871] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hirotsu Y, Otake S, Ohyama H, Amemiya K, Higuchi R, Oyama T, Mochizuki H, Goto T, Omata M. Dual-molecular barcode sequencing detects rare variants in tumor and cell free DNA in plasma. Sci Rep 2020;10:3391. [PMID: 32099048 DOI: 10.1038/s41598-020-60361-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
8 Hirotsu Y, Hada M, Amemiya K, Oyama T, Mochizuki H, Omata M. Multi-regional sequencing reveals clonal and polyclonal seeding from primary tumor to metastases in advanced gastric cancer. J Gastroenterol 2020;55:553-64. [PMID: 31912238 DOI: 10.1007/s00535-019-01659-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Hirotsu Y, Yokoyama H, Amemiya K, Hagimoto T, Daimon H, Hosaka K, Oyama T, Mochizuki H, Omata M. Genomic profile of urine has high diagnostic sensitivity compared to cytology in non-invasive urothelial bladder cancer. Cancer Sci 2019;110:3235-43. [PMID: 31368627 DOI: 10.1111/cas.14155] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
10 Oura H, Matsumura T, Kawasaki Y, Okimoto K, Ishikawa K, Kaneko T, Tokunaga M, Oike T, Imai Y, Yokoyama Y, Akizue N, Maruoka D, Ohta Y, Saito K, Nakagawa T, Arai M, Kato J, Kato N. Long-term use of proton pump inhibitors does not affect ectopic and metachronous recurrence of gastric cancer after endoscopic treatment. Scand J Gastroenterol 2020;55:209-15. [PMID: 32008404 DOI: 10.1080/00365521.2020.1720796] [Reference Citation Analysis]